The measurement and clinical relevance of brain atrophy in multiple sclerosis

Lancet Neurology

Volumn 5, Issue 2, 2006, Pages 158-170

  Bermel, Robert A ^a   Bakshi, Rohit ^b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1A INTERFERON; GLATIRAMER; PLACEBO;

BRAIN ATROPHY; BRAIN SIZE; CLINICAL TRIAL; DISEASE COURSE; DRUG EFFECT; HUMAN; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PHENOTYPE; PHYSICAL DISABILITY; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW;

ATROPHY; BRAIN; DISEASE PROGRESSION; HUMANS; MAGNETIC RESONANCE IMAGING; MULTIPLE SCLEROSIS; PROGNOSIS;

EID: 30844464790     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(06)70349-0     Document Type: Review

References (144)

1. R Carswell Pathological anatomy: illustrations of the elementary forms of disease 1838 Longman, Orme, Browne, Green, and Longman London
2. E Rindfleisch Histologisches detail zu der grauen degeneration von gehirn und ruckenmark Arch of Pathol Anatomy Physiol 26 1863 474 483
3. KR Gross, TA Tomberg, AA Kokk, AE Kaasik The prognosis of multiple sclerosis: computed tomographic comparisons Zh Nevropatol Psikhiatr Im S S Korsakova 93 1993 32 35
4. X Lin, CR Tench, N Evangelou, T Jaspan, CS Constantinescu Measurement of spinal cord atrophy in multiple sclerosis J Neuroimaging 14 3 suppl 2004 20 26
5. RA Rudick Impact of disease-modifying therapies on brain and spinal cord atrophy in multiple sclerosis J Neuroimaging 14 3 suppl 2004 54 64
6. R Zivadinov, R Bakshi Central nervous system atrophy and clinical status in multiple sclerosis J Neuroimaging 14 3 suppl 2004 27 35
7. MA Rocca, SJ Hickman, L Bo Imaging the optic nerve in multiple sclerosis Mult Scler 11 2005 537 541
8. JH Simon Brain and spinal cord atrophy in multiple sclerosis Neuroimaging Clin N Am 10 2000 753 770
9. A Minagar, EG Toledo, JS Alexander, RE Kelley Pathogenesis of brain and spinal cord atrophy in multiple sclerosis J Neuroimaging 14 3 suppl 2004 5 10
10. W Bruck, A Bitsch, H Kolenda, Y Bruck, M Stiefel, H Lassmann Inflammatory central nervous system demyelination: correlation of magnetic resonance imaging findings with lesion pathology Ann Neurol 42 1997 783 793
11. R Bakshi, A Minagar, Z Jaisani, JS Wolinsky Imaging of multiple sclerosis: role in neurotherapeutics Neuro Rx 2 2005 277 303
12. A Bitsch, T Kuhlmann, C Stadelmann, H Lassmann, C Lucchinetti, W Bruck A longitudinal MRI study of histopathologically defined hypointense multiple sclerosis lesions Ann Neurol 49 2001 793 796
13. MA van Walderveen, W Kamphorst, P Scheltens Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis Neurology 50 1998 1282 1288
14. DS Meier, HL Weiner, SJ Khoury, CR Guttmann Magnetic resonance imaging surrogates of multiple sclerosis pathology and their relationship to central nervous system atrophy J Neuroimaging 14 3 suppl 2004 46 53
15. DT Chard, PA Brex, O Ciccarelli The longitudinal relation between brain lesion load and atrophy in multiple sclerosis: a 14 year follow up study J Neurol Neurosurg Psychiatry 74 2003 1551 1554
16. CM Dalton, DT Chard, GR Davies Early development of multiple sclerosis is associated with progressive grey matter atrophy in patients presenting with clinically isolated syndromes Brain 127 2004 1101 1107
17. RA Rudick, E Fisher, JC Lee, J Simon, L Jacobs Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS. Multiple sclerosis collaborative research group Neurology 53 1999 1698 1704
18. RA Bermel, SR Puli, RA Rudick Prediction of longitudinal brain atrophy in multiple sclerosis by gray matter magnetic resonance imaging T2 hypointensity Arch Neurol 62 2005 1371 1376
19. Y Ge, RI Grossman, JK Udupa, JS Babb, LG Nyul, DL Kolson Brain atrophy in relapsing-remitting multiple sclerosis: fractional volumetric analysis of gray matter and white matter Radiology 220 2001 606 610
20. DT Chard, CM Griffin, GJ Parker, R Kapoor, AJ Thompson, DH Miller Brain atrophy in clinically early relapsing-remitting multiple sclerosis Brain 125 2002 327 337
21. M Quarantelli, A Ciarmiello, VB Morra Brain tissue volume changes in relapsing-remitting multiple sclerosis: correlation with lesion load Neuroimage 18 2003 360 366
22. G Tedeschi, L Lavorgna, P Russo Brain atrophy and lesion load in a large population of patients with multiple sclerosis Neurology 65 2005 280 285
23. MP Sanfilipo, RH Benedict, J Sharma, B Weinstock-Guttman, R Bakshi The relationship between whole brain volume and disability in multiple sclerosis: a comparison of normalized gray vs white matter with misclassification correction Neuroimage 26 2005 1068 1077
24. RA Bermel, MD Innus, CW Tjoa, R Bakshi Selective caudate atrophy in multiple sclerosis: A 3D MRI parcellation study Neuroreport 14 2003 335 339
25. R Zivadinov, M Zorzon Is gadolinium enhancement predictive of the development of brain atrophy in multiple sclerosis? A review of the literature J Neuroimaging 12 2002 302 309
26. TP Leist, MI Gobbini, JA Frank, HF McFarland Enhancing magnetic resonance imaging lesions and cerebral atrophy in patients with relapsing multiple sclerosis Arch Neurol 58 2001 57 60
27. TL Luks, DE Goodkin, SJ Nelson A longitudinal study of ventricular volume in early relapsing-remitting multiple sclerosis Mult Scler 6 2000 332 337
28. M Rovaris, G Comi, MA Rocca, JS Wolinsky, M Filippi European/Canadian Glatiramer Acetate Study Group Short-term brain volume change in relapsing-remitting multiple sclerosis: effect of glatiramer acetate and implications Brain 124 2001 1803 1812
29. JH Simon, LD Jacobs, MK Campion A longitudinal study of brain atrophy in relapsing multiple sclerosis Neurology 53 1999 139 148
30. R Zivadinov, F Bagnato, D Nasuelli Short-term brain atrophy changes in relapsing-remitting multiple sclerosis J Neurol Sci 223 2004 185 193
31. AM Saindane, Y Ge, JK Udupa, JS Babb, LJ Mannon, RI Grossman The effect of gadolinium-enhancing lesions on whole brain atrophy in relapsing-remitting MS Neurology 55 2000 61 65
32. PD Molyneux, L Kappos, C Polman The effect of interferon beta-1b treatment on MRI measures of cerebral atrophy in secondary progressive multiple sclerosis: European study group on interferon beta-1b in secondary progressive multiple sclerosis Brain 123 2000 2256 2263
33. A Paolillo, AJ Coles, PD Molyneux Quantitative MRI in patients with secondary progressive MS treated with monoclonal antibody campath 1H Neurology 53 1999 751 757
34. A Paolillo, C Pozzilli, C Gasperini Brain atrophy in relapsing-remitting multiple sclerosis: Relationship with 'black holes', disease duration and clinical disability J Neurol Sci 174 2000 85 91
35. RA Bermel, J Sharma, CW Tjoa, SR Puli, R Bakshi A semiautomated measure of whole-brain atrophy in multiple sclerosis J Neurol Sci 208 2003 57 65
36. RA Bermel, R Bakshi, C Tjoa, SR Puli, L Jacobs Bicaudate ratio as a magnetic resonance imaging marker of brain atrophy in multiple sclerosis Arch Neurol 59 2002 275 280
37. BD Trapp, J Peterson, R Ransohoff, R Rudick, E Al Axonal transection in the lesions of multiple sclerosis N Engl J Med 338 1998 278
38. JH Simon, RP Kinkel, L Jacobs, L Bub, N Simonian A Wallerian degeneration pattern in patients at risk for MS Neurology 54 2000 1155 1160
39. Y Ge, O Gonen, M Inglese, JS Babb, CE Markowitz, RI Grossman Neuronal cell injury precedes brain atrophy in multiple sclerosis Neurology 62 2004 624 627
40. N De Stefano, G Iannucci, MP Sormani MR correlates of cerebral atrophy in patients with multiple sclerosis J Neurol 249 2002 1072 1077
41. C Enzinger, S Ropele, S Smith Accelerated evolution of brain atrophy and "black holes" in MS patients with APOE-epsilon 4 Ann Neurol 55 2004 563 569
42. R Bakshi, J Dmochowski, ZA Shaikh, L Jacobs Gray matter T2 hypointensity is related to plaques and atrophy in the brains of multiple sclerosis patients J Neurol Sci 185 2001 19 26
43. R Bakshi, RH Benedict, RA Bermel T2 hypointensity in the deep gray matter of patients with multiple sclerosis: a quantitative magnetic resonance imaging study Arch Neurol 59 2002 62 68
44. R Bakshi, RH Benedict, RA Bermel, L Jacobs Regional brain atrophy is associated with physical disability in multiple sclerosis: Semiquantitative magnetic resonance imaging and relationship to clinical findings J Neuroimaging 11 2001 129 136
45. N De Stefano, PM Matthews, M Filippi Evidence of early cortical atrophy in MS: relevance to white matter changes and disability Neurology 60 2003 1157 1162
46. M Tiberio, DT Chard, DR Altmann Gray and white matter volume changes in early RRMS: a 2-year longitudinal study Neurology 64 2005 1001 1007
47. J Sastre-Garriga, GT Ingle, DT Chard, L Ramio-Torrenta, DH Miller, AJ Thompson Grey and white matter atrophy in early clinical stages of primary progressive multiple sclerosis Neuroimage 22 2004 353 359
48. Sanfilipo MP, Benedict RHB, Weinstock-Guttman B, Bakshi R. Gray and white matter brain atrophy and neuropsychological impairment in multiple sclerosis. Neurology (in press).
49. M Sailer, B Fischl, D Salat Focal thinning of the cerebral cortex in multiple sclerosis Brain 126 2003 1734 1744
50. DT Chard, CM Griffin, W Rashid Progressive grey matter atrophy in clinically early relapsing-remitting multiple sclerosis Mult Scler 10 2004 387 391
51. JW Peterson, L Bo, S Mork, A Chang, BD Trapp Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions Ann Neurol 50 2001 389 400
52. A Cifelli, M Arridge, P Jezzard, MM Esiri, J Palace, PM Matthews Thalamic neurodegeneration in multiple sclerosis Ann Neurol 52 2002 650
53. I Taylor Serial MRI in multiple sclerosis: A prospective pilot study of lesion load, whole brain volume and thalamic atrophy J Clin Neurosci 11 2004 153 158
54. R Bakshi, RS Miletich, PR Kinkel, ML Emmet, WR Kinkel High-resolution fluorodeoxyglucose positron emission tomography shows both global and regional cerebral hypometabolism in multiple sclerosis J Neuroimaging 8 1998 228 234
55. M Filippi, MA Rocca, B Colombo Functional magnetic resonance imaging correlates of fatigue in multiple sclerosis Neuroimage 15 2002 559 567
56. M Inglese, Y Ge, M Filippi, A Falini, RI Grossman, O Gonen Indirect evidence for early widespread gray matter involvement in relapsing-remitting multiple sclerosis Neuroimage 21 2004 1825 1829
57. AJ Fabiano, J Sharma, B Weinstock-Guttman Thalamic involvement in multiple sclerosis: a diffusion-weighted magnetic resonance imaging study J Neuroimaging 13 2003 307 314
58. JH Simon Linear and regional measures of brain atrophy in multiple sclerosis Zivadinov R Bakshi R Brain and spinal cord atrophy in multiple sclerosis 2004 Nova Science Hauppauge 15 27
59. JH Simon, RB Schiffer, RA Rudick, RM Herndon Quantitative determination of MS-induced corpus callosum atrophy in vivo using MR imaging AJNR Am J Neuroradiol 8 1987 599 604
60. RH Benedict, B Weinstock-Guttman, I Fishman, J Sharma, CW Tjoa, R Bakshi Prediction of neuropsychological impairment in multiple sclerosis: Comparison of conventional magnetic resonance imaging measures of atrophy and lesion burden Arch Neurol 61 2004 226 230
61. C Caon, M Zvartau-Hind, W Ching, RP Lisak, AC Tselis, OA Khan Intercaudate nucleus ratio as a linear measure of brain atrophy in multiple sclerosis Neurology 60 2003 323 325
62. D Berg, M Maurer, M Warmuth-Metz, P Rieckmann, G Becker The correlation between ventricular diameter measured by transcranial sonography and clinical disability and cognitive dysfunction in patients with multiple sclerosis Arch Neurol 57 2000 1289 1292
63. BA Kallmann, J Sauer, M Schliesser Determination of ventricular diameters in multiple sclerosis patients with transcranial sonography (TCS): a two year follow-up study J Neurol 251 2004 30 34
64. J Sharma, MP Sanfilipo, RH Benedict, B Weinstock-Guttman, FE Munschauer 3rd, R Bakshi Whole-brain atrophy in multiple sclerosis measured by automated versus semiautomated MR imaging segmentation AJNR Am J Neuroradiol 25 2004 985 996
65. MP Sormani, M Rovaris, P Valsasina, JS Wolinsky, G Comi, M Filippi Measurement error of two different techniques for brain atrophy assessment in multiple sclerosis Neurology 62 2004 1432 1434
66. D Pelletier, K Garrison, R Henry Measurement of whole-brain atrophy in multiple sclerosis J Neuroimaging 14 3 suppl 2004 11 19
67. MP Sanfilipo, RH Benedict, R Zivadinov, R Bakshi Correction for intracranial volume in analysis of whole brain atrophy in multiple sclerosis: the proportion vs. residual method Neuroimage 22 2004 1732 1743
68. Y Ge, RI Grossman, JK Udupa Brain atrophy in relapsing-remitting multiple sclerosis and secondary progressive multiple sclerosis: longitudinal quantitative analysis Radiology 214 2000 665 670
69. JK Udupa, D Odhner, S Samarasekera 3DVIEWNIX: An open, transportable, multidimensional, multimodality, multiparametric imaging software system SPIE Proc 2164 1994 58 73
70. SM Smith, Y Zhang, M Jenkinson Accurate, robust, and automated longitudinal and cross-sectional brain change analysis Neuroimage 17 2002 479 489
71. D Pelletier, SJ Nelson, J Oh MRI lesion volume heterogeneity in primary progressive MS in relation with axonal damage and brain atrophy J Neurol Neurosurg Psychiatry 74 2003 950 952
72. CK Jones, A Riddehough, DKB Li, G Zhao, DW Paty MRI cerebral atrophy in relapsing-remitting MS: results from the PRISMS trial Neurology 56 2001 A379
73. DL Collins, J Montagnat, AP Zijdenbos, AC Evans, DL Arnold Automated estimation of brain volume in multiple sclerosis with BICCR Lect Notes Comput Sci 2001 141 147
74. MJ Hohol, CR Guttmann, J Orav Serial neuropsychological assessment and magnetic resonance imaging analysis in multiple sclerosis Arch Neurol 54 1997 1018 1025
75. JK Udupa, L Wei, S Samarasekera, Y Miki, MA van Buchem, RI Grossman Detection and quantification of MS lesions using fuzzy topological principles Proc SPIE 2710 1996 81 91
76. B Alfano, A Brunetti, M Larobina Automated segmentation and measurement of global white matter lesion volume in patients with multiple sclerosis J Magn Reson Imaging 12 2000 799 807
77. CM Dalton, PA Brex, R Jenkins Progressive ventricular enlargement in patients with clinically isolated syndromes is associated with the early development of multiple sclerosis J Neurol Neurosurg Psychiatry 73 2002 141 147
78. C Lukas, HK Hahn, B Bellenberg Sensitivity and reproducibility of a new fast 3D segmentation technique for clinical MR-based brain volumetry in multiple sclerosis Neuroradiology 46 2004 906 915
79. NC Fox, R Jenkins, SM Leary Progressive cerebral atrophy in MS: A serial study using registered, volumetric MRI Neurology 54 2000 807 812
80. SM Smith, N De Stefano, M Jenkinson, PM Matthews Normalized accurate measurement of longitudinal brain change J Comput Assist Tomogr 25 2001 466 475
81. J Ashburner, KJ Friston Voxel-based morphometry: the methods Neuroimage 11 2000 805 821
82. DT Chard, GJ Parker, CM Griffin, AJ Thompson, DH Miller The reproducibility and sensitivity of brain tissue volume measurements derived from an SPM-based segmentation methodology J Magn Reson Imaging 15 2002 259 267
83. J Kassubek, H Tumani, D Ecker, A Kurt, AC Ludolph, FD Juengling Age-related brain parenchymal fraction is significantly decreased in young multiple sclerosis patients: a quantitative MRI study Neuroreport 14 2003 427 430
84. CRG Guttmann, R Benson, SK Warfield White matter abnormalities in mobility-impaired older persons Neurology 54 2000 1277 1283
85. R Zivadinov, A Grop, J Sharma Reproducibility and accuracy of quantitative magnetic resonance imaging techniques of whole-brain atrophy measurement in multiple sclerosis J Neuroimaging 15 2005 27 36
86. A Paolillo, MC Piattella, P Pantano The relationship between inflammation and atrophy in clinically isolated syndromes suggestive of multiple sclerosis: a monthly MRI study after triple-dose gadolinium-DTPA J Neurol 251 2004 432 439
87. PA Brex, R Jenkins, NC Fox Detection of ventricular enlargement in patients at the earliest clinical stage of MS Neurology 54 2000 1689 1691
88. WI McDonald, A Compston, G Edan Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis Ann Neurol 50 2001 121 127
89. M Filippi, M Rovaris, M Inglese Interferon beta-1a for brain tissue loss in patients at presentation with syndromes suggestive of multiple sclerosis: a randomised, double-blind, placebo-controlled trial Lancet 364 2004 1489 1496
90. R Zivadinov, J Sepcic, D Nasuelli A longitudinal study of brain atrophy and cognitive disturbances in the early phase of relapsing-remitting multiple sclerosis J Neurol Neurosurg Psychiatry 70 2001 773 780
91. NF Kalkers, N Ameziane, JC Bot, A Minneboo, CH Polman, F Barkhof Longitudinal brain volume measurement in multiple sclerosis: rate of brain atrophy is independent of the disease subtype Arch Neurol 59 2002 1572 1576
92. IT Redmond, S Barbosa, LD Blumhardt, N Roberts Short-term ventricular volume changes on serial MRI in multiple sclerosis Acta Neurol Scand 102 2000 99 105
93. M Inglese, M Rovaris, L Giacomotti, G Mastronardo, G Comi, M Filippi Quantitative brain volumetric analysis from patients with multiple sclerosis: a follow-up study J Neurol Sci 171 1999 8 10
94. R Zivadinov, R Bakshi Role of MRI in multiple sclerosis II: brain and spinal cord atrophy Front Biosci 9 2004 647 664
95. X Lin, LD Blumhardt, CS Constantinescu The relationship of brain and cervical cord volume to disability in clinical subtypes of multiple sclerosis: a three-dimensional MRI study Acta Neurol Scand 108 2003 401 406
96. NA Losseff, L Wang, HM Lai Progressive cerebral atrophy in multiple sclerosis: a serial MRI study Brain 119 1996 2009 2019
97. Y Ge, RI Grossman, JK Udupa Glatiramer acetate (Copaxone) treatment in relapsing-remitting MS: quantitative MR assessment Neurology 54 2000 813 817
98. B Turner Cerebral atrophy and disability in relapsing-remitting and secondary progressive multiple sclerosis over four years Mult Scler 9 2003 21 27
99. JS Wolinsky, PA Narayana, KP Johnson Multiple Sclerosis Study Group and the MRI Analysis Center United states open-label glatiramer acetate extension trial for relapsing multiple sclerosis: MRI and clinical correlates. multiple sclerosis study group and the MRI analysis center Mult Scler 7 2001 33 41
100. C Gasperini, A Paolillo, E Giugni MRI brain volume changes in relapsing-remitting multiple sclerosis patients treated with interferon beta-1a Mult Scler 8 2002 119 123
101. M Filippi, M Rovaris, G Iannucci, S Mennea, MP Sormani, G Comi Whole brain volume changes in patients with progressive MS treated with cladribine Neurology 55 2000 1714 1718
102. VL Stevenson, DH Miller, SM Leary One year follow up study of primary and transitional progressive multiple sclerosis J Neurol Neurosurg Psychiatry 68 2000 713 718
103. GT Ingle, VL Stevenson, DH Miller, AJ Thompson Primary progressive multiple sclerosis: a 5-year clinical and MR study Brain 126 2003 2528 2536
104. SM Leary, DH Miller, VL Stevenson, PA Brex, DT Chard, AJ Thompson Interferon beta-1a in primary progressive MS: an exploratory, randomized, controlled trial Neurology 60 2003 44 51
105. F Barkhof MRI in multiple sclerosis: correlation with expanded disability status scale (EDSS) Mult Scler 5 1999 283 286
106. P Dastidar, T Heinonen, T Lehtimaki Volumes of brain atrophy and plaques correlated with neurological disability in secondary progressive multiple sclerosis J Neurol Sci 165 1999 36 42
107. E Fisher, RA Rudick, JH Simon Eight-year follow-up study of brain atrophy in patients with MS Neurology 59 2002 1412 1420
108. RH Benedict, DA Carone, R Bakshi Correlating brain atrophy with cognitive dysfunction, mood disturbances, and personality disorder in multiple sclerosis J Neuroimaging 14 3 suppl 2004 36 45
109. V Janardhan, R Bakshi Quality of life and its relationship to brain lesions and atrophy on magnetic resonance images in 60 patients with multiple sclerosis Arch Neurol 57 2000 1485 1491
110. R Bakshi, D Czarnecki, ZA Shaikh Brain MRI lesions and atrophy are related to depression in multiple sclerosis Neuroreport 11 2000 1153 1158
111. MP Amato, G Ponziani, G Pracucci, L Bracco, G Siracusa, L Amaducci Cognitive impairment in early-onset multiple sclerosis: pattern, predictors, and impact on everyday life in a 4-year follow-up Arch Neurol 52 1995 168 172
112. SM Rao, GJ Leo, L Bernardin, F Unverzagt Cognitive dysfunction in multiple sclerosis: frequency, patterns, and prediction Neurology 41 1991 685 691
113. P Kujala, R Portin, J Ruutiainen The progress of cognitive decline in multiple sclerosis: a controlled 3-year follow-up Brain 120 1997 289 297
114. WW Beatty, DE Goodkin, N Monson, PA Beatty Cognitive disturbances in patients with relapsing remitting multiple sclerosis Arch Neurol 46 1989 1113 1119
115. I Litvan, J Grafman, P Vendrell Multiple memory deficits in patients with multiple sclerosis: exploring the working memory system Arch Neurol 45 1988 607 610
116. I Grant, WI McDonald, MR Trimble, E Smith, R Reed Deficient learning and memory in early and middle phases of multiple sclerosis J Neurol Neurosurg Psychiatry 47 1984 250 255
117. HA Demaree, J DeLuca, EA Gaudino, BJ Diamond Speed of information processing as a key deficit in multiple sclerosis: implications for rehabilitation J Neurol Neurosurg Psychiatry 67 1999 661 663
118. SM Rao, S Glatt, TA Hammeke Chronic progressive multiple sclerosis. relationship between cerebral ventricular size and neuropsychological impairment Arch Neurol 42 1985 678 682
119. M Rovaris, M Filippi MRI correlates of cognitive dysfunction in multiple sclerosis patients J Neurovirol 6 suppl 2 2000 172 175
120. SJ Huber, RA Bornstein, KW Rammohan, JA Christy, DW Chakeres, RB McGhee Magnetic resonance imaging correlates of neuropsychological impairment in multiple sclerosis J Neuropsychiatry Clin Neurosci 4 1992 152 158
121. J Pelletier, L Suchet, T Witjas A longitudinal study of callosal atrophy and interhemispheric dysfunction in relapsing-remitting multiple sclerosis Arch Neurol 58 2001 105 111
122. M Zorzon, R Zivadinov, D Nasuelli Depressive symptoms and MRI changes in multiple sclerosis Eur J Neurol 9 2002 491 496
123. A Feinstein, P Roy, N Lobaugh, K Feinstein, P O'Connor, S Black Structural brain abnormalities in multiple sclerosis patients with major depression Neurology 62 2004 586 590
124. C Christodoulou, LB Krupp, Z Liang Cognitive performance and MR markers of cerebral injury in cognitively impaired MS patients Neurology 60 2003 1793 1798
125. RH Benedict, R Zivadinov, DA Carone Regional lobar atrophy predicts memory impairment in multiple sclerosis AJNR Am J Neuroradiol 26 2005 1824 1831
126. X Wei, CR Guttmann, SK Warfield, M Eliasziw, JR Mitchell Has your patient's multiple sclerosis lesion burden or brain atrophy actually changed? Mult Scler 10 2004 402 406
127. MA Horsfield, M Rovaris, MA Rocca Whole-brain atrophy in multiple sclerosis measured by two segmentation processes from various MRI sequences J Neurol Sci 216 2003 169 177
128. C Gasperini, M Rovaris, MP Sormani Intra-observer, inter-observer and inter-scanner variations in brain MRI volume measurements in multiple sclerosis Mult Scler 7 2001 27 31
129. N Gordon Apparent cerebral atrophy in patients on treatment with steroids Dev Med Child Neurol 22 1980 502 506
130. EL Hoogervorst, CH Polman, F Barkhof Cerebral volume changes in multiple sclerosis patients treated with high-dose intravenous methylprednisolone Mult Scler 8 2002 415 419
131. AB Rao, N Richert, T Howard Methylprednisolone effect on brain volume and enhancing lesions in MS before and during IFNbeta-1b Neurology 59 2002 688 694
132. RJ Fox, E Fisher, J Tkach, JC Lee, JA Cohen, RA Rudick Brain atrophy and magnetization transfer ratio following methylprednisolone in multiple sclerosis: short-term changes and long-term implications Mult Scler 11 2005 140 145
133. R Zivadinov, RA Rudick, R De Masi Effects of IV methylprednisolone on brain atrophy in relapsing-remitting MS Neurology 57 2001 1239 1247
134. RA Rudick, E Fisher, JC Lee, JT Duda, J Simon Brain atrophy in relapsing multiple sclerosis: Relationship to relapses, EDSS, and treatment with interferon beta-1a Mult Scler 6 2000 365 372
135. A Pato-Pato, JM Prieto, M Lema, D Dapena-Bolano, J Abella-Corral, JM Pumar Cerebral atrophy in multiple sclerosis patients treated periodically with boluses of methylprednisolone Rev Neurol 37 2003 501 506
136. R Bakshi, VSR Dandamudi, M Neema, C De, RA Bermel Measurement of brain and spinal cord atrophy by magentic resonance imaging as a tool to monitor multiple sclerosis J Neuroimaging 15 4 suppl 2005 30S 45S
137. M Hardmeier, S Wagenpfeil, P Freitag Rate of brain atrophy in relapsing MS decreases during treatment with IFNbeta-1a Neurology 64 2005 236 240
138. Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis: PRISMS (prevention of relapses and disability by interferon beta-1a subcutaneously in multiple sclerosis) study group Lancet 352 1998 1498 1504
139. Secondary Progressive Efficacy Clinical Trial of Recombinant Interferon-beta-1a in MS (SPECTRIMS) Study Group: randomized controlled trial of interferon-beta-1a in secondary progressive MS - clinical results Neurology 56 2001 1496 1504
140. X Lin, CR Tench, B Turner, LD Blumhardt, CS Constantinescu Spinal cord atrophy and disability in multiple sclerosis over four years: application of a reproducible automated technique in monitoring disease progression in a cohort of the interferon beta-1a (rebif) treatment trial J Neurol Neurosurg Psychiatry 74 2003 1090 1094
141. JA Frank, N Richert, C Bash Interferon-beta-1b slows progression of atrophy in RRMS: Three-year follow-up in NAb- and NAb+ patients Neurology 62 2004 719 725
142. DH Miller Biomarkers and surrogate outcomes in neurodegenerative disease: lessons from multiple sclerosis NeuroRx 1 2004 284 294
143. K Biernacki, JP Antel, M Blain, S Narayanan, DL Arnold, A Prat Interferon beta promotes nerve growth factor secretion early in the course of multiple sclerosis Arch Neurol 62 2005 563 568
144. VW Yong, S Chabot, O Stuve, G Williams Interferon beta in the treatment of multiple sclerosis: Mechanisms of action Neurology 51 1998 682 689